Targeted delivery of therapeutic oligonucleotides in pancreatic cancer
Published: 12 July 2022
Journal of Biology and Medicine , Volume 6, pp 001-004; https://doi.org/10.17352/jbm.000028
Abstract: Currently, the most common treatment options for pancreatic cancer include chemotherapy, radiation, and surgery. These treatment options are not specific to the cause of the disease and therefore result in a large number of side effects including nausea, fatigue, hair loss, etc. The use of oligonucleotides may be a more efficient and safe method of cancer therapy. This mini-review will cover how oligonucleotides have been used to treat diseases in the past as well as different methods for delivery into the body and finally the applications of oligonucleotides in pancreatic cancer therapy.
Keywords: pancreatic cancer / treatment / oligonucleotides / loss / chemotherapy / side / mini / surgery / efficient / nausea
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Journal of Biology and Medicine" .